Batu Biologics Recruits Cancer Immunologist to Scientific Advisory Board
Collaboration of IND-enabling experiments for ValloVax™ with Dr. Fang
Batu Biologics, an immunotherapy company working to develop ValloVax, an anti-angiogenic cancer vaccine, announced today the addition of Dr. Deyu Fang to its Scientific Advisory Board.
Batu Biologics Recruits Inventor of Licensed UCSD Cancer Immunotherapy to Scientific Advisory Board
Dr. Messmer to Assist in the Clinical Development of the ValloVax™ Lung Cancer Vaccine
Batu Biologics, an immunotherapy company developing the ValloVax™ anti-angiogenic lung cancer vaccine, announced today the addition Dr. Davorka Messmer to its Scientific Advisory Board (SAB).
